Bladder Cancer Global Clinical Trials Review, H2, 2015

Date: August 19, 2015
Pages: 105
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B5A1545AA2AEN
Leaflet:

Download PDF Leaflet

Bladder Cancer Global Clinical Trials Review, H2, 2015

SUMMARY

GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2015' provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Bladder Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Bladder Cancer
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Bladder Cancer
Aug 10, 2015: BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma
Jul 13, 2015: In a pivotal study, Roche’s investigational immunotherapy atezolizumab shrank tumours in people with a specific type of bladder cancer
Jun 01, 2015: Roche presents encouraging update on metastatic bladder cancer data for atezolizumab (MPDL3280A, anti-PDL1)
Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer
May 20, 2015: OncoGenex To Present Phase II Study Data On Apatorsen At ASCO 2015 Annual Meeting
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline Plc
Clinical Trial Overview of GlaxoSmithKline Plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Oncogenex Pharmaceuticals, Inc.
Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
AstraZeneca Plc
Clinical Trial Overview of AstraZeneca Plc
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
SWOG
Clinical Trial Overview of SWOG
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Clinical Trial Overview of Eastern Cooperative Oncology Group
Medical Research Council
Clinical Trial Overview of Medical Research Council
University Hospitals Birmingham NHS Foundation Trust
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust
University of Chicago
Clinical Trial Overview of University of Chicago
Aarhus University
Clinical Trial Overview of Aarhus University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015
Bladder Cancer Therapeutics, Global, Suspended Clinical Trials, 2015
Bladder Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015
Bladder Cancer Therapeutics, Global, Terminated Clinical Trials, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015

LIST OF FIGURES

Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology

COMPANIES MENTIONED

GlaxoSmithKline Plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Pfizer Inc.
Novartis AG
Celgene Corporation
Oncogenex Pharmaceuticals, Inc.
Bayer AG
AstraZeneca Plc
Skip to top


Ask Your Question

Bladder Cancer Global Clinical Trials Review, H2, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: